CoChat

Standards for Clinical Trials in Sexual Dysfunction in Women: Research Designs and Outcomes Assessment

Clayton, Anita H., Dennerstein, Lorraine, Fisher, William A., Kingsberg, Sheryl A., Perelman, Michael A., Pyke, Robert E. · 2010 · The Journal of Sexual Medicine
Cited by 47

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Introduction: Clinical trial design in female sexual dysfunction (FSD) is an evolving science, with some areas of controversy. Aim: To develop an evidence-based, expert consensus-report on design of FSD clinical research. Methods: Literature review including the Food and Drug Administration (FDA) clinical trial guidelines with critique by six experts from three countries, modified after public presentation and debate. Main Outcome Measure: Expert opinion and recommendations were based on grading of evidence based literature, internal committee dialogue, open presentation, and debate. Results: Design of clinical research for regulatory approval is driven by FDA guidelines. Diagnostic and Statistical Manual-IV definitions and consideration of comorbidity of sexual disorders may complicate patient selection and outcomes. Measures for study end points include satisfying sexual events utilizing a daily diary, sexual distress, and patient-reported outcomes measures of the construct under study. Currently, trial duration is recommended to be 6 months for efficacy trials to allow for modification of behavioral adaptations to changes in desire. Important issues include safety assessments, generalizability, having a representative study population, stratification by reproductive status, partner assessment, contextual and interpersonal factors, symptom duration and severity, management of placebo response, and drug dosing. Statistical analysis should include assessment of change from baseline to end point between study drug and placebo, determination of statistically significant change vs. clinically meaningful effects, linear mapping of all measures of the same construct, and determination of responders and remitters. Conclusions: Future trials should include clear population definitions, direct and indirect measures of the specific FSD construct, and procedures to allow generalizability of diagnosis and treatment to the target population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1743-6109.2009.01628.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 47

Metadata

Authors
Clayton, A. H., Dennerstein, L., Fisher, W. A., Kingsberg, S. A., Perelman, M. A., & Pyke, R. E.
Venue
The Journal of Sexual Medicine
Published
2010-01-01
Volume
7
Issue
1_Part_2
Pages
541-560
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W2094446562
Cited by
47
References
11
FWCI
3.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Standards for Clinical Trials in Sexual Dysfunction in Women: Research Designs and Outcomes Assessment. https://app.cochat.ai/papers/10.1111/j.1743-6109.2009.01628.x
The paper
Clayton, A. H., Dennerstein, L., Fisher, W. A., Kingsberg, S. A., Perelman, M. A., & Pyke, R. E. (2010). Standards for Clinical Trials in Sexual Dysfunction in Women: Research Designs and Outcomes Assessment. The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2009.01628.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.